Peak6 Investments LLC Iovance Biotherapeutics, Inc. Call Options Transaction History

Peak6 Investments LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$7.78 - $14.19 $58,350 - $106,425	-7,500 Reduced 23.08%	25,000 $200,000
Q1 2024 May 14, 2024	BUY	$7.59 - $17.47 $246,675 - $567,775	32,500 New	32,500 $481,000
Q1 2022 May 13, 2022	SELL	$12.38 - $19.1 $207,984 - $320,880	-16,800 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $481,656 - $883,512	16,800 New	16,800 $532,000

323

239M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.52B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.